Compare AbCellera Biologics Inc (ABCL) vs Redwire Corporation (RDW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Redwire Corporation — how do they compare? AbCellera Biologics Inc trades at $9.1 (market cap $2.99B), while Redwire Corporation trades at $13.51 (market cap $3.38B). The key difference: AbCellera Biologics Inc and Redwire Corporation are close in size by market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Redwire Corporation nearer its low. Which is the better fit depends on your goals.
| ABCL | RDW | |
|---|---|---|
Market Cap | $2.99B | $3.38B |
Sector | Health | Technology |
52-Week High | $9.76 | $25.90 |
52-Week Low | $2.78 | $5.06 |
Enterprise Value | $2.58B | $2.91B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Redwire Corporation
Redwire Corporation is a pure-play space infrastructure company that provides a wide range of advanced solutions for the next generation of space exploration and utilization. The company's capabilities span critical space technology, including on-orbit servicing, satellite components, space robotics, and digital engineering. Redwire's products and services are used by civil, commercial, and national security customers to enable missions from low Earth orbit to deep space.
Read more on RDW →
